Rochester General Hospital, an affiliate hospital of Rochester Regional Health, is a 528-bed tertiary care hospital, located in Rochester, New York. Rochester General Hospital has been serving the residents of the Rochester Region and beyond since 1847.

There are 528 beds in Rochester General Hospital.

During the past decade, Rochester General Hospital conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 26 clinical trials were completed, i.e. on average, 56.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 12 clinical trials were completed. i.e. 109.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rochester General Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 13 trials, followed by "Boston Scientific Corporation" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "Rochester General Hospital" with 5 trials sponsored and "Celgene" with 5 trials sponsored. Other sponsors include 65 different institutions and companies that sponsored additional 57 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rochester General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 4 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "Rochester General Hospital" with 3 trials as a collaborator and "Medical University of South Carolina" with 2 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 58 trials.

According to Clinical.Site data, the most researched conditions in "Rochester General Hospital" are "Stroke" (6 trials), "Crohn's Disease" (5 trials), "Breast Cancer" (4 trials), "Coronary Artery Disease" (4 trials) and "Cerebrovascular Accident" (3 trials). Many other conditions were trialed in "Rochester General Hospital" in a lesser frequency.

Most popular intervention types in "Rochester General Hospital" are "Drug" (63 trials), "Other" (32 trials), "Device" (18 trials), "Biological" (15 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Laboratory Biomarker Analysis" (10 trials), "Quality-of-Life Assessment" (9 trials), "Biospecimen Collection" (6 trials) and "Computed Tomography" (6 trials). Other intervention names were less common.

The vast majority of trials in "Rochester General Hospital" are 96 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Rochester General Hospital". undefined are not yet recruiting, 15 are recruiting, 24 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 47 completed trials in Rochester General Hospital, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Rochester General Hospital, 6 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 19 trials that are defined as “Not Applicable".